Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 11, 2013 - Issue 1
Submit an article Journal homepage
42
Views
9
CrossRef citations to date
0
Altmetric
Editorial

In search of the optimal delivery method for anti-HIV microbicides: are intravaginal rings the way forward?

Nina Derby Center for Biomedical Research, Population Council, 1230 York Avenue, New York, NY 10065, USA
,
Thomas Zydowsky Center for Biomedical Research, Population Council, 1230 York Avenue, New York, NY 10065, USA
&
Melissa Robbiani Center for Biomedical Research, Population Council, 1230 York Avenue, New York, NY 10065, USA. [email protected]
Pages 5-8 | Published online: 10 Jan 2014

References

  • Abdool Karim Q, Abdool Karim SS, Frohlich JA et al.; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329(5996), 1168–1174 (2010).
  • Kiser PF, Johnson TJ, Clark JT. State of the art in intravaginal ring technology for topical prophylaxis of HIV infection. AIDS Rev. 14(1), 62–77 (2012).
  • Romano JW, Robbiani M, Doncel GF, Moench T. Non-specific microbicide product development: then and now. Curr. HIV Res. 10(1), 9–18 (2012).
  • Grant RM, Lama JR, Anderson PL et al.; iPrEx Study Team. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 363(27), 2587–2599 (2010).
  • Karim SS, Kashuba AD, Werner L, Karim QA. Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women. Lancet 378(9787), 279–281 (2011).
  • Anderson PL, Glidden DV, Liu A et al.; For the iPrEx Study Team. Emtricitabine–tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci. Transl. Med. 4(151), 151ra125 (2012).
  • van der Straten A, Van Damme L, Haberer JE, Bangsberg DR. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS 26(7), F13–F19 (2012).
  • Malcolm RK, Edwards KL, Kiser P, Romano J, Smith TJ. Advances in microbicide vaginal rings. Antiviral Res. 88(Suppl. 1), S30–S39 (2010).
  • van der Straten A, Montgomery ET, Cheng H et al. High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women. AIDS Behav. 16(7), 1775–1786 (2012).
  • Montgomery ET, van der Straten A, Cheng H et al. Vaginal ring adherence in sub-saharan Africa: expulsion, removal, and perfect use. AIDS Behav. 16(7), 1787–1798 (2012).
  • Singer R, Mawson P, Derby N et al. An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques. Sci. Transl. Med. 4(150), 150ra123 (2012).
  • Kenney J, Aravantinou M, Singer R et al. An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques. PLoS ONE 6(1), e15835 (2011).
  • Dobard C, Sharma S, Martin A et al. Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue. J. Virol. 86(2), 718–725 (2012).
  • Romano J, Variano B, Coplan P et al. Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring. AIDS Res. Hum. Retroviruses 25(5), 483–488 (2009).
  • Malcolm RK, Veazey RS, Geer L et al. Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques. Antimicrob. Agents Chemother. 56(5), 2251–2258 (2012).
  • Clark JT, Johnson TJ, Clark MR et al. Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir. J. Control. Release 163(2), 240–248 (2012).
  • Johnson TJ, Clark MR, Albright TH et al. A ninety day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis. Antimicrob. Agents Chemother. 56(12), 6272–6283 (2012).
  • Johnson TJ, Gupta KM, Fabian J, Albright TH, Kiser PF. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. Eur. J. Pharm. Sci. 39(4), 203–212 (2010).
  • Baum MM, Butkyavichene I, Gilman J et al. An intravaginal ring for the simultaneous delivery of multiple drugs. J. Pharm. Sci. 101(8), 2833–2843 (2012).
  • Moss JA, Malone AM, Smith TJ et al. Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring. Antimicrob. Agents Chemother. 56(2), 875–882 (2012).
  • Fernández-Romero JA, Abraham CJ, Rodriguez A et al. Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge. Antimicrob. Agents Chemother. 56(1), 358–368 (2012).
  • Han YA, Singh M, Saxena BB. Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents. Contraception 76(2), 132–138 (2007).
  • Nuttall J, Kashuba A, Wang R et al. Pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques. Antimicrob. Agents Chemother. 56(1), 103–109 (2012).
  • Aravantinou M, Singer R, Derby N et al. The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT infection. AIDS Res. Hum. Retroviruses 28(11), 1467–1475 (2012).
  • Kenney J, Singer R, Derby N et al. A single dose of a MIV-150/zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8–24 h after gel use. AIDS Res. Hum. Retroviruses 28(11), 1476–1484 (2012).
  • Parikh UM, Dobard C, Sharma S et al. Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine. J. Virol. 83(20), 10358–10365 (2009).
  • Gunawardana M, Moss JA, Smith TJ et al. Microbial biofilms on the surface of intravaginal rings worn in non-human primates. J. Med. Microbiol. 60(Pt 6), 828–837 (2011).
  • Garg S, Goldman D, Krumme M, Rohan LC, Smoot S, Friend DR. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets. Antiviral Res. 88(Suppl. 1), S19–S29 (2010).
  • Ball CS, Krogstad EK, Chaowanachan TC, Woodrow KA. Nanofibers for HIV-1 inhibition and contraception. PLoS ONE doi:10.1371/journal.pone.0049792 (2012).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.